MOTS-C

🔹 What is MOTS-C ?

Class: Mitochondrial-derived peptide — a 16-amino acid peptide (sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Leu-Phe-Tyr-Pro-Arg-Lys-Leu-Arg, MW 2288.6 g/mol) encoded directly by the mitochondrial genome rather than nuclear DNA, which is unusual and part of what makes it mechanistically distinct from most peptides. Skeletal muscle is its primary target organ. Mechanism:

• Acts as a mitochondrial signaling peptide that regulates metabolism and stress responses.
• Can be considered an “exercise mimetic” — it activates AMPK, increases GLUT4 glucose transporter uptake in muscle, and improves insulin sensitivity/decreases insulin resistance, which is why animal studies show improved glucose metabolism even on a high-fat diet.
• Enhances AMPK activation → improves glucose uptake, fatty acid oxidation, and insulin sensitivity.
• Supports mitochondrial biogenesis and protects against metabolic dysfunction.
• Influences exercise capacity, endurance, and recovery by optimizing cellular energy utilization.
• Promotes “browning” of white fat and increases brown adipose tissue thermogenic activity, likely mediated via the ERK signaling pathway — relevant to its metabolic/weight management effects.
• Increases intracellular NAD+ levels via SIRT1, and activates AMPK — tying into cellular energy regulation and exercise adaptation (mitohormesis).
• Being studied as a potential biomarker for metabolic health, with levels inversely correlated with markers of insulin resistance.

Primary focus:

• Metabolic optimization (insulin sensitivity, glucose regulation, fat metabolism).
• Exercise performance and endurance.
• Anti-aging and mitochondrial resilience.
• Neuroprotective and cytoprotective roles.
• Cardiovascular protection — research suggests MOTS-c may protect against vascular calcification and myocardial remodeling via AMPK activation.
• Bone health — research suggests a role in osteoporosis prevention.

---

🔹 Oral Dosage: Not effective; rapidly degraded in the digestive system.

---

🔹 Injectable / Subcutaneous Dosage (most common) Range:

• Typical research use: 5–15 mg per week, divided into 2–3 doses.
• Common dosing patterns: 5 mg 2–3x per week, or 10 mg once weekly.

Frequency: Subcutaneous injection, often pre- or post-training for performance focus. Rationale: Regular pulses support mitochondrial adaptation and metabolic benefits without desensitization.

---

🔹 Cycle Length

• Common cycles: 4–12 weeks.
• Often used in blocks around training seasons or metabolic reset periods.
• Breaks of 2–4 weeks are typical before restarting.

---

🔹 Optimal Dosing Window

• Morning or pre-training is preferred for energy and endurance benefits.
• Can also be taken post-exercise to aid recovery and mitochondrial biogenesis.

---

✅ Educational Integration Example

• Example protocol: 5 mg MOTS-c, 2x/week (Mon/Thu), subcutaneous injection, for 8 weeks.
• Paired with: Exercise regimen, balanced nutrition, NAD⁺ support.
• Clinical pearl: The injection can cause local pruritus/irritation for 5–15 minutes. Some practitioners split the dose into two syringes and inject into both glutes to reduce the intensity of this reaction. Typical clinical protocol: once weekly for 4–6 weeks.

---

🔹 Stacking Strategy (Educational / Complementary) Since MOTS-c is a mitochondrial optimizer and metabolic regulator, stacking tends to emphasize energy support, recovery, and longevity: 🔸 Mitochondrial & Energy Metabolism:

• NAD⁺ precursors (NMN, NR) or direct NAD⁺ therapy: Synergize with AMPK activation.
• AICAR, L-Carnitine, CoQ10, PQQ: Complement mitochondrial energy flux and fatty acid oxidation.

🔸 Performance & Recovery:

• GH secretagogues (CJC-1295/Ipamorelin, or Tesamorelin): Support lean mass and recovery alongside mitochondrial function.
• BPC-157 or TB-500: Add tissue repair and systemic recovery benefits.

🔸 Anti-Aging & Longevity:

• Epitalon: Cellular aging pathway modulation (telomeres).
• FOXO4-DRI or Senolytics: Synergize with MOTS-c’s resilience effects for long-term vitality.
• Melanotan-1 (MT-1): Protective skin/tissue support during increased energy utilization.

Rationale: MOTS-c shines as a metabolic reset peptide, so stacks often combine mitochondrial boosters, recovery peptides, and longevity agents.

---

⚠️ Safety Notes:

• Generally considered well-tolerated in research use.
• Possible mild side effects: injection site irritation, fatigue, or mild headaches.
• Human clinical research is still early—long-term safety not fully established.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.